[Comparison of the bronchodilating activity of procaterol and nicardipine in chronic forms of bronchial asthma].
The bronchodilatory activity of one beta 2-stimulation (procaterol) and one calcium antagonist (nicardipine) both recently introduced was compared in a group of chronic asthmatics in the clinical remission phase. The experiment took the form of the randomised double blind administration of procaterol or nicardipine or a placebo twice a day for 15 days with spirometric tests being performed before, during and after the experiment. The results show that nicardipine does have a bronchodilatory effect though less than the beta 2-stimulant.
D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D004311:Double-Blind Method; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009529:Nicardipine / Q000627:therapeutic use*; D017265:Procaterol; D011897:Random Allocation
D001993:Bronchodilator Agents; D004983:Ethanolamines; D009529:Nicardipine; D017265:Procaterol
Raffronto tra l'attività broncodilatatoria del procaterolo e della nicardipina nelle forme croniche di asma bronchiale.